*NURSING > CASE STUDY > NR 503 Week 6 Assignment: Epidemiological Analysis: Chronic Health Problem – COPD (All)
Evaluation Epidemiological Problem: COPD in Kentucky Chronic obstructive pulmonary disease (COPD) is a chronic lung disease that is a major cause of disability and is the third leading cause of dea... th in the United States (National Heart, Lung, and Blood Institute, 2013). More than 11 million people have been diagnosed with COPD but millions of others live with this chronic disease undiagnosed (American Lung Association, 2016). The World Health Organization (WHO) estimated that COPD will rank fifth in the global burden of disease by 2020 (as cited in Kamour, Mannino, & Kanotra, 2015). The prevalence of COPD in the U.S. was 6.1% in 2011 and increased with age (as cited in Kamour, Mannino, & Kanotra, 2015). Worldwide, about 3 million deaths were caused by COPD in 2015 (WHO, 2016). In the state of Kentucky, lung disease is the third leading cause of death (Centers for Disease Control and Prevention (CDC), 2016b). Kentucky ranked the highest of all 50 states in prevalence of COPD at 9.3% (American Lung Association, 2013). CO [Show More]
Last updated: 1 year ago
Preview 1 out of 15 pages
NR 503 Week 1 Quiz: Acknowledgement Practice Quiz: Academic Writer NR-503 Week 1 Discussion: Exercise and Discussion Questions from Curley Textbook: Chapter 1, Exercise 1.5 NR 503 Week 1 Discussion:...
By A+ Solutions 1 year ago
$14.5
37
NR 503 Week 6 Assignment: Epidemiological Analysis: Chronic Health Problem – COPD NR-503 Week 6 Assignment: Epidemiological Analysis: Chronic Health Problem – Multiple sclerosis NR 503 Week 6 As...
By A+ Solutions 1 year ago
$14.5
4
Connected school, study & course
About the document
Uploaded On
Nov 28, 2022
Number of pages
15
Written in
This document has been written for:
Uploaded
Nov 28, 2022
Downloads
0
Views
76
In Browsegrades, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.
We're available through e-mail, Twitter, Facebook, and live chat.
FAQ
Questions? Leave a message!
Copyright © Browsegrades · High quality services·